Exploring the Impact of the Ponesimod Point Study on Advancing Medical Treatments
The Ponesimod study, particularly the OPTIMUM Phase 3 trial, marks a significant milestone in the treatment of relapsing multiple sclerosis (MS). It highlights the sustained efficacy of ponesimod in reducing relapses and MRI lesions, while also comparing its effectiveness against other therapies. Delve into the mechanisms, safety profile, and long-term impacts on brain health that […]
3 minute read